Overview

Colchicine and CRP in Atrial Fibrillation and AF Ablation

Status:
Completed
Trial end date:
2016-12-06
Target enrollment:
Participant gender:
Summary
Colchicine will lower C-reactive protein (CRP) in chronic atrial fibrillation and reduce the rise in CRP which occurs following atrial fibrillation ablation
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
Detiger Funds
Takeda
Treatments:
Colchicine